drugset / Trial / NCT00144521
Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the clinical efficacy and safety of MRA in a double-blind, parallel-group, controlled study using MRA or methotrexate (MTX) in rheumatoid arthritis (RA) patients with MTX administered.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-08
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 8 mg | Oral |
| Subject | Tocilizumab | Monoclonal antibody | 8 mg/kg | Intravenous |